The United Nations health agency has warned that the spread of an HIV strain resistant to some of the most widely used medicines could undermine global progress in treating and preventing HIV infection if early and effective action is not taken.
Antimicrobial drug resistance is a growing challenge to global health and sustainable development, said Tedros Adhanom Ghebreyesus, the Director-General of the World Health Organization (WHO), in a news release.
We need to proactively address the rising levels of resistance to HIV drugs if we are to achieve the global target of ending AIDS by 2030, he added.
According to the WHO HIV drug resistance report 2017 in six of the 11 countries surveyed in Africa, Asia and Latin America, more than 10 per cent of people starting antiretroviral therapy had a strain that was resistant to some of the most widely used medicines.
Once the threshold of 10 per cent has been reached, WHO recommends those countries urgently review their HIV treatment programmes.
Source: UN NEWS Centre